Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
43,068,701
-
Shares change
-
+1,862,436
-
Total reported value, excl. options
-
$1,459,854,294
-
Value change
-
-$99,787,937
-
Put/Call ratio
-
69%
-
Number of buys
-
80
-
Number of sells
-
69
-
Price
-
$33.89
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q2 2024
As of 30 Jun 2024 Immunocore Holdings plc - Ordinary shares (IMCR) had 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,068,701 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, FMR LLC, T. Rowe Price Investment Management, Inc., PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, GENERAL ATLANTIC, L.P., Bellevue Group AG, and ARMISTICE CAPITAL, LLC.
This table shows 135 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.